India has now outlined the details of a large-scale incentive scheme for manufacturers of certain critical active pharmaceutical ingredients (APIs) and drug intermediates in the country as it seeks to galvanize the domestic industry and shrink dependence on China.
The ministry of chemicals and fertilizers has provided the specifics of a production-linked incentive scheme to bolster domestic manufacturing of critical APIs, key starting materials (KSMs) and drug intermediates. The...